Holen Sie sich die Stockscreener-App
2.54
4.96%
0.12
Schlusskurs vom Vortag:
$2.42
Offen:
$2.42
24-Stunden-Volumen:
11,594
Relative Volume:
0.01
Marktkapitalisierung:
$5.82M
Einnahmen:
$2.54M
Nettoeinkommen (Verlust:
$-4.13M
KGV:
-0.9236
EPS:
-2.75
Netto-Cashflow:
$-4.11M
1W Leistung:
-1.55%
1M Leistung:
-10.88%
6M Leistung:
-17.28%
1J Leistung:
-43.93%
1-Tages-Spanne:
$2.36
$2.54
1-Wochen-Bereich:
$2.31
$2.7208
52-Wochen-Spanne:
$2.20
$13.93
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Firmenname
Xenetic Biosciences Inc
Sektor
Branche
Telefon
781-778-7720
Adresse
945 CONCORD ST., FRAMINGHAM, MA
Vergleichen Sie XBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
2.54 | 5.54M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-08 | Eingeleitet | Maxim Group | Buy |
Xenetic Biosciences Inc Aktie (XBIO) Neueste Nachrichten
Will Xenetic Biosciences Inc. stock keep outperforming rivals2025 Buyback Activity & Risk Controlled Stock Alerts - Newser
Is Xenetic Biosciences Inc. (3XB0) stock a top hedge fund pick2025 Top Gainers & Reliable Volume Spike Trade Alerts - Newser
Is Xenetic Biosciences Inc. (3XB0) stock a buy for dividend portfoliosWeekly Stock Report & Real-Time Sentiment Analysis - Newser
Xenetic Biosciences, Inc. (XBIO) Jumps 10% in Pre-market: What’s Driving the Move? - Stocks Telegraph
Can Xenetic Biosciences Inc. (3XB0) stock reach $200 price targetJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Is Xenetic Biosciences Inc. (3XB0) stock a fit for income portfoliosEarnings Beat & Technical Pattern Alert System - Newser
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock - Courier & Press
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform - Times Record News
Is Xenetic Biosciences Inc. (3XB0) stock bottoming after sell offWeekly Trade Summary & Weekly Hot Stock Watchlists - Newser
Xenetic Biosciences (XBIO) Stock Analysis Report | Financials & Insights - Benzinga
What analysts say about Xenetic Biosciences Inc stockPortfolio Diversification Tips & Exceptional Profit Trading - earlytimes.in
Published on: 2025-11-28 02:47:25 - BỘ NỘI VỤ
Xenetic Biosciences Inc. (XBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Xenetic Biosciences Inc. (3XB0) stock prepared for digital transitionJuly 2025 Selloffs & Trade Opportunity Analysis Reports - newser.com
How Xenetic Biosciences Inc. (3XB0) stock reacts to weak economyJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Is Xenetic Biosciences Inc. forming a reversal patternJuly 2025 Rallies & Safe Capital Allocation Plans - newser.com
Is Xenetic Biosciences Inc. stock bottoming outJuly 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Long term hold vs stop loss in Xenetic Biosciences Inc.Quarterly Performance Summary & Expert-Curated Trade Recommendations - newser.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Xenetic Biosciences extends collaboration with Scripps Research By Investing.com - Investing.com Nigeria
What hedge fund activity signals for Xenetic Biosciences Inc. stock - newser.com
Xenetic Biosciences extends collaboration with Scripps Research - Investing.com
Xenetic (XBIO) Extends Collaboration With Scripps to Boost Cance - GuruFocus
Xenetic Biosciences (NASDAQ: XBIO) extends 4-month Scripps DNase I CAR-T collaboration toward Phase 1 - Stock Titan
Will Xenetic Biosciences Inc. stock split attract more investorsMarket Growth Summary & Weekly Top Gainers Trade List - newser.com
Finanzdaten der Xenetic Biosciences Inc-Aktie (XBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):